MBL77 - AN OVERVIEW

Deep, focused up coming-technology sequencing has revealed that subclonal mutations (i.e., those present in just a portion of tumor cells) is often detected for all driver genes and so are associated with immediate disease development and poor outcome.11–13 This is particularly appropriate for TP53 mutations provided The truth that, as discussed